Abstract
Sixty-nine patients presenting over a 10-year period with peritoneal carcinomatosis from appendiceal cancer were treated with cytoreductive surgery combined with intraperitoneal chemotherapy. The three-year survival is 89.5 percent in patients (38/69) with pseudomyxoma peritonei, 34.5 percent in patients (25/69) with cystadenocarcinoma, and 38.1 percent in patients (6/69) with adenocarcinoma ( P <0.01). In this study, a classification of residual disease following the cytoreductive surgery was used. The prognosis of the patients with minimal residual disease was better than that of those with moderate or gross disease, showing a 91.6 percent three-year survival compared with 47.8 percent and 20 percent, respectively ( P <0.01). The patients without lymphatic or hematogenous metastases had a better three-year survival than those with metastases (75.1 percent vs.28.6 percent; P <0.01). These findings suggest that peritoneal carcinomatosis from appendiceal cancer can be treated with long-term disease-free survival. The patients with low malignant potential cancer, complete cytoreduction, and no metastases showed the most effective disease control.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pugeda FV, Hinshaw JP. Primary adenocarcinoma of the appendix. Dis Colon Rectum 1969;12:457–61.
Gilhome RW, Johnston DH, Clark J, Kyle J. Primary adenocarcinoma of the vermiform appendix: report of a series of ten cases, and review of the literature. Br J Surg 1984;71:553–5.
Lyss AP. Appendiceal malignancies. Semin Oncol 1988;2:129–37.
Sugarbaker PH. Cancer of the appendix and pseudomyxoma peritonei. In: Fazio VW, ed. Current therapy in colon and rectal surgery. Philadelphia: BC Decker, 1990:295–301.
Sugarbaker PH. Curative treatment of peritoneal carcinomatosis from grade I mucinous adenocarcinoma. Surg Rounds 1988;11:45–63.
Sugarbaker PH. Surgical treatment of peritoneal carcinomatosis. Can J Surg 1989:32(Suppl 3):164–70.
Sugarbaker PH. Cytoreductive approach to peritoneal carcinomatosis: peritonectomy and intraperitoneal chemotherapy. Postgrad Adv Colorectal Surg 1991;I–X:1–13.
Sugarbaker PH. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16(Suppl 4):83–97.
Sugarbaker PH, Landy D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 1990;65:1495–501.
Author information
Authors and Affiliations
About this article
Cite this article
Sugarbaker, P.H., Zhu, BW., Sese, G.B. et al. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 36, 323–329 (1993). https://doi.org/10.1007/BF02053933
Issue Date:
DOI: https://doi.org/10.1007/BF02053933